Risks Of Blood Substitute Drugs Merit Return To Toxicology Studies – JAMA

The toxicities of developmental hemoglobin-based oxygen carriers must be defined in preclinical animal testing replicating the products' known toxicities in humans before further humans trials are allowed to proceed, the authors of a study published April 28 in the Journal of the American Medical Association argue